Stay updated on CAB-AXL-ADC Study in NSCLC Clinical Trial
Sign up to get notified when there's something new on the CAB-AXL-ADC Study in NSCLC Clinical Trial page.

Latest updates to the CAB-AXL-ADC Study in NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant content removal, particularly regarding a clinical study on CAB-AXL-ADC for non-small-cell lung cancer, including detailed study objectives, criteria, and previous version information. The only notable addition is a new revision number.SummaryDifference12%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for January 13, 2025. However, the deletion of the date March 25, 2025, does not significantly impact the core content.SummaryDifference0.5%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
Stay in the know with updates to CAB-AXL-ADC Study in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAB-AXL-ADC Study in NSCLC Clinical Trial page.